CompletedNCT03844269

Electroencephalogram (EEG) Study of Inattention Following Treatment With AKL-T01

Device studyAges 8–12United StatesADHD

The study in practice

Understand this study

Listed age limits: 8 years to 12 years.

Listed locations: San Rafael, United StatesSee all locations and recruitment
Activities: Device procedures described in the protocol
Compensation: Payment and expense reimbursement have not been verified.

Study clarity

Study start dateStarted: May 10, 2019

Recruitment status: Completed
Enrollment listed in the registry: 28
Sponsor: Akili Interactive Labs, Inc.
Sponsor type: Other organization
Study type: Device
Intervention type: DEVICE
Study phase: Not clearly listed
Locations: United States
Age range: From 8 Years to 12 Years
Official registry ID: NCT03844269
Official title: Show the full official title
A Study to Assess Midline Frontal Theta (MFT) Power as Measured by Stimulus-locked Electroencephalography (EEG) Before and After AKL-T01 Treatment for Improving Attention in Pediatric Participants Ages 8-12 Years Old With Attention Deficit Hyperactivity Disorder (ADHD)

Completed

San Rafael

FAQ

Who is behind this study?

The study sponsor is Akili Interactive Labs, Inc.

Who was this study for?

Listed age limits: 8 years to 12 years.

Explore other studies

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.